Poster Session 1-26 Multiple Myeloma: Clinical Studies (1)

[PS1-26-1] Real-world progression-free survival 2 in myeloma patients: a cohort study in KTMM study group

Yutaka Tsukune¹, Makoto Sasaki¹, Atsushi Isoda², Akio Saito², Norina Tanaka³, Shigeki Ito⁴, Hideto Tamura⁵, Hiroshi Handa⁶, Michiaki Koike⁷, Sakae Tanosaki⁸, Yoichi Imai⁹, Takeshi Odajima¹⁰, Hiroki Sugimori¹¹, Junji Tanaka³, Mariko Ishibashi¹², Norio Komatsu¹ (1.Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan, 2.Department of Hematology, Shibukawa Medical Center, Shibukawa, Japan, 3.Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan, 4.Department of Medical Oncology, Iwate Medical University, Morioka, Japan, 5.Department of Hematology, Nippon Medical School, Tokyo, Japan, 6.Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, 7.Department of Hematology, Juntendo University Shizuoka Hospital, Izunokuni, Japan, 8.Department of Hematology, The Fraternity Memorial Hospital, Tokyo, Japan, 9.Department of Hematology/Oncology, IMSUT Hospital, The Institute of Medical Science, 10.Faculty of Health Science, Daito Bunka University, Higashimatsuyama, Japan, 11.Department of Preventive Medicine, Daito Bunka University, Higashimatsuyama, Japan, 12.Department of Microbiology and Immunology, Nippon Medical School, Tokyo, Japan)